Defining the road map to a UK national lung cancer screening programme
Authors
O'Dowd, E. L.Lee, R. W.
Akram, A. R.
Bartlett, E. C.
Bradley, S. H.
Brain, K.
Callister, M. E. J.
Chen, Y.
Devaraj, A.
Eccles, S. R.
Field, J. K.
Fox, J.
Grundy, S.
Janes, S. M.
Ledson, M.
MacKean, M.
Mackie, A.
McManus, K. G.
Murray, R. L.
Nair, A.
Quaife, S. L.
Rintoul, R.
Stevenson, A.
Summers, Yvonne J
Wilkinson, L. S.
Booton, R.
Baldwin, D. R.
Crosbie, P.
Affiliation
Nottingham University Hospitals NHS Trust, Nottingham, UKIssue Date
2023
Metadata
Show full item recordAbstract
Lung cancer screening with low-dose CT was recommended by the UK National Screening Committee (UKNSC) in September, 2022, on the basis of data from trials showing a reduction in lung cancer mortality. These trials provide sufficient evidence to show clinical efficacy, but further work is needed to prove deliverability in preparation for a national roll-out of the first major targeted screening programme. The UK has been world leading in addressing logistical issues with lung cancer screening through clinical trials, implementation pilots, and the National Health Service (NHS) England Targeted Lung Health Check Programme. In this Policy Review, we describe the consensus reached by a multiprofessional group of experts in lung cancer screening on the key requirements and priorities for effective implementation of a programme. We summarise the output from a round-table meeting of clinicians, behavioural scientists, stakeholder organisations, and representatives from NHS England, the UKNSC, and the four UK nations. This Policy Review will be an important tool in the ongoing expansion and evolution of an already successful programme, and provides a summary of UK expert opinion for consideration by those organising and delivering lung cancer screenings in other countries.Citation
O'Dowd EL, Lee RW, Akram AR, Bartlett EC, Bradley SH, Brain K, et al. Defining the road map to a UK national lung cancer screening programme. The Lancet Oncology. 2023 May;24(5):e207-e18. PubMed PMID: 37142382. Epub 2023/05/05. eng.Journal
Lancet OncologyDOI
10.1016/s1470-2045(23)00104-3PubMed ID
37142382Additional Links
https://dx.doi.org/10.1016/s1470-2045(23)00104-3Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/s1470-2045(23)00104-3
Scopus Count
Collections
Related articles
- Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study.
- Authors: Jallow M, Black G, van Os S, Baldwin DR, Brain KE, Donnelly M, Janes SM, Kurtidu C, McCutchan G, Robb KA, Ruparel M, Quaife SL
- Issue date: 2022 Aug
- The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
- Authors: Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rintoul RC, Screaton N, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Hansell DM
- Issue date: 2016 May
- Lung cancer screening - gaining consensus on next steps - proceedings of a closed workshop in the UK.
- Authors: Moffat J, Hiom S, Kumar HS, Baldwin DR
- Issue date: 2018 Nov
- What happens after an NHS Health Check? A survey and realist review.
- Authors: Duddy C, Gadsby E, Hibberd V, Krska J, Wong G
- Issue date: 2023 Jul
- Engaging with stakeholders to inform the development of a decision-support tool for the NHS health check programme: qualitative study.
- Authors: Hyseni L, Guzman-Castillo M, Kypridemos C, Collins B, Schwaller E, Capewell S, Boland A, Dickson R, O'Flaherty M, Gallacher K, Hale P, Lloyd-Williams F
- Issue date: 2020 May 11